ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,433Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 939

$1.06M Total Retail Price of All Prescriptions

Rank: 37 out of 939

954 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 954 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 954 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 20,796 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 1,451 1,134 1 2
LISINOPRIL 911 674 2 3
FUROSEMIDE 887 748 3 7
POTASSIUM CHLORIDE 858 744 4 9
HYDROCODONE-ACETAMINOPHEN 752 506 S3 5 1
OMEPRAZOLE 698 548 6 5
LEVOTHYROXINE SODIUM 638 579 7 4
METFORMIN HCL 638 450 7 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 598 490 9 23
WARFARIN SODIUM 557 496 10 17
AMLODIPINE BESYLATE 531 437 11 6
TRAMADOL HCL 525 413 12 16
CITALOPRAM HBR 498 326 13 15
MELOXICAM 497 337 14 14
HYDROCHLOROTHIAZIDE 456 341 15 12
GABAPENTIN 456 329 15 11
METOPROLOL TARTRATE 414 344 17 10
DONEPEZIL HCL 350 342 18 30
ATENOLOL 327 271 19 19
GLIMEPIRIDE 315 289 20 37
METOPROLOL SUCCINATE 295 266 21 21
LOVASTATIN 289 268 22 46
ATORVASTATIN CALCIUM 266 187 23 22
CIPROFLOXACIN HCL 261 199 24 54
ALLOPURINOL 260 209 25 31
PRAVASTATIN SODIUM 258 202 26 13
ZOLPIDEM TARTRATE 237 163 27 20
CLOPIDOGREL 226 177 28 28
MIRTAZAPINE 214 199 29 56
NEXIUM 202 123 30 18
LANTUS 199 128 31 59
CARVEDILOL 198 150 32 25
VENTOLIN HFA 191 109 33 80
AZITHROMYCIN 182 140 34 32
ALENDRONATE SODIUM 182 178 34 40
NAMENDA 177 177 36 49
TAMSULOSIN HCL 173 156 37 27
SPIRONOLACTONE 168 108 38 71
POLYETHYLENE GLYCOL 3350 168 146 38 57
DOXYCYCLINE HYCLATE 167 119 40 84
FAMOTIDINE 166 135 41 62
CLONIDINE HCL 165 113 42 39
GLYBURIDE 163 137 R 43 89
ISOSORBIDE MONONITRATE ER 161 103 44 53
SERTRALINE HCL 160 129 45 24
TRIAMTERENE-HCTZ 159 129 46 33
PLAVIX 154 128 47 48
LOSARTAN-HYDROCHLOROTHIAZIDE 148 120 48 55
AMITRIPTYLINE HCL 144 82 R 49 38
DILTIAZEM ER 144 111 49 94
RAMIPRIL 139 122 51 91
PHENYTOIN SODIUM EXTENDED 138 57 52 99
PREDNISONE 136 75 53 42
AGGRENOX 130 129 54 153
DIOVAN 129 85 55 50
MORPHINE SULFATE ER 129 30 S2 55 113
RISPERIDONE 126 112 57 82
SULFAMETHOXAZOLE-TRIMETHOPRIM 125 86 58 64
PROAIR HFA 115 64 59 41
DIVALPROEX SODIUM 112 88 60 95
TIZANIDINE HCL 111 66 61 81
DIGOXIN 105 92 62 45
TRAZODONE HCL 104 58 63 26
ESTRADIOL 99 55 R 64 79
INSULIN SYRINGE 99 71 64 97
QUETIAPINE FUMARATE 97 69 66 69
EVISTA 95 95 67 122
DOXAZOSIN MESYLATE 95 79 67 108
SYNTHROID 94 94 69 75
GLIPIZIDE 93 49 70 52
LOSARTAN POTASSIUM 93 81 70 29
NIFEDIPINE ER 93 66 70 105
METHADONE HCL 90 48 S2 73 109
FLUOXETINE HCL 88 74 74 47
PAROXETINE HCL 86 50 75 70
FLUTICASONE PROPIONATE 86 60 75 43
ROPINIROLE HCL 86 51 75 78
CYMBALTA 86 37 75 44
MUPIROCIN 84 72 79 185
LANTUS SOLOSTAR 83 78 80 128
TERAZOSIN HCL 81 69 81 114
ESCITALOPRAM OXALATE 77 51 82 61
VYTORIN 76 55 83 216
GLIPIZIDE XL 74 36 84 147
VERAPAMIL ER 74 60 84 85
JANUVIA 73 47 86 110
DIOVAN HCT 72 50 87 74
SEROQUEL 72 63 87 139
CRESTOR 71 60 89 34
KLOR-CON M20 71 41 89 90
PREMARIN 69 50 R 91 111
DILTIAZEM 24HR ER 68 44 92 253
SPIRIVA 67 40 93 73
QUINAPRIL HCL 64 47 94 133
RANITIDINE HCL 62 42 95 35
PROPRANOLOL HCL 61 50 96 117
FLUCONAZOLE 61 35 96 140
FINASTERIDE 61 38 96 131
SINGULAIR 60 51 99 101
CYCLOBENZAPRINE HCL 60 12 R 99 36
PANTOPRAZOLE SODIUM 60 28 99 66
DETROL LA 58 53 102 155
PROMETHAZINE HCL 57 20 R 103 68
FENTANYL 55 43 S2 104 104
HYDRALAZINE HCL 54 28 105 130
LIPITOR 53 39 106 127
NOVOLOG 52 30 107 145
COMBIVENT 52 37 107 120
DIPYRIDAMOLE 52 52 R 107 398
NYSTATIN 50 45 110 174
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.